Pamicell Signs Supply Contract Worth 1 Billion KRW
[Asia Economy Reporter Oh Ju-yeon] Pharmicell announced on the 7th that it has signed a supply contract for pharmaceutical intermediates mPEGs worth 997.65 million KRW with the US company Nektar Therapeutics. This corresponds to 3.07% of recent sales revenue.
Hot Picks Today
"Do We Need to Panic Buy Again?" War Drives 30% Price Surge... Even the Bedroom Feels the Impact
- "Suspicious Timing?"...Trump Traded Stocks After Praising Wartime Capabilities
- Trump: "U.S. and Nigerian Forces Eliminate IS Number Two Worldwide"
- "Anyone Who Visited the Room Salon, Come Forward"… Gangnam Police Station Launches Full Staff Investigation After New Scandal
- "Contact Me First If Houses Are Built": Wealthy Clients Eyeing... Will Ultra-High-End Residences Worth 20 Billion Won Be Developed? [Real Estate AtoZ]
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
